RELAY THERAPEUTICS INC (RLAY) Stock Cash Flow
NASDAQ:RLAY - Nasdaq - US75943R1023 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -333.39M | -337.71M | -341.97M | -290.51M | -363.87M | |||
| Depreciation Amortization | 5.28M | 5.46M | 5.27M | 4.13M | 3.93M | |||
| Change In Working Capital | -8.44M | 14.62M | -32.46M | 11.25M | 97.34M | |||
| Other non cash items | 64.55M | 68.52M | 68.85M | 45.64M | 188.20M | |||
| OPERATING CASH FLOW | -271.99M | -249.11M | -300.32M | -229.49M | -74.41M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -622.00K | -2.02M | -4.13M | -9.06M | -3.47M | |||
| Other Investing Activity | -8.53M | -39.06M | 261.76M | -179.68M | -476.04M | |||
| INVESTING CASH FLOW | -9.15M | -41.08M | 257.63M | -188.75M | -479.51M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 270.15M | 34.75M | 289.91M | 388.09M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 221.23M | 270.15M | 34.75M | 289.91M | 388.09M | |||
| CHANGE IN CASH | -59.91M | -20.04M | -7.93M | -128.33M | -165.83M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -271.99M | -249.11M | -300.32M | -229.49M | -74.41M | |||
| Capital Expenditure | -622.00K | -2.02M | -4.13M | -9.06M | -3.47M | |||
| FREE CASH FLOW | -272.62M | -251.13M | -304.44M | -238.55M | -77.88M | |||
All data in USD